ULTRASENSITIVE C-REACTIVE PROTEIN - ANVISA Registration 10269360470
Access comprehensive regulatory information for ULTRASENSITIVE C-REACTIVE PROTEIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10269360470 and manufactured by QUIBASA QUÍMICA BÁSICA LTDA. The registration is held by QUIBASA - QUIMICA BASICA LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including LABTEST DIAGNOSTICA S/A, BIOSYSTEMS S.A., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
10269360470
25351073040202588
19400787000107
Company Information
Dates and Status
Jun 09, 2025
VIGENTE
09/18/2025 19:00:01
PROTEÍNA C REATIVA ULTRASSENSÍVEL
FASTLINE FIA CRP
HANGZHOU ALLTEST BIOTECH CO. LTD
80105220272
Jun 16, 2025
PROTEÍNA C REATIVA ULTRASSENSÍVEL
CRP Quantitative Test Kit (Time-Resolved FIA)
ZHEJIANG ORIENT GENE BIOTECH CO., LTD.
82444370223
Apr 07, 2025
PROTEÍNA C REATIVA ULTRASSENSÍVEL
Celer Finecare X PCR/us-PCR Quantitativo
GUANGZHOU WONDFO BIOTECH CO. LTD
80537410131
Mar 05, 2025
PROTEÍNA C REATIVA ULTRASSENSÍVEL
Família CRP High Sensitivity
THERMO FISHER SCIENTIFIC OY
80254180477
Mar 05, 2025
PROTEÍNA C REATIVA ULTRASSENSÍVEL
Família AutoLumo hs-PCR Micropartículas (CLIA)
AUTOBIO DIAGNOSTICS CO., LTD
80102513379
Feb 24, 2025

